Page 1 | Search Results | Blood Advances | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice

Archana Shrestha, Mengna Chi, Kimberly Wagner, Astha Malik, Jennifer Korpik, Adam Drake, Keertik Fulzele, Sylvie Guichard, Punam Malik

Blood Adv (2021) 5 (9): 2385–2390.

https://doi.org/10.1182/bloodadvances.2020003604

Published: 2021

Includes: Supplemental data

Journal Articles

Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products

Christine W. Bruggeman, Sietse Q. Nagelkerke, Wendy Lau, Cedric Manlhiot, Masja de Haas, Robin van Bruggen, Brian W. McCrindle, Rae S. M. Yeung, Taco W. Kuijpers

Blood Adv (2020) 4 (14): 3416–3426.

https://doi.org/10.1182/bloodadvances.2020002253

Published: 2020

Includes: Supplemental data

Journal Articles

Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes

Kimberly Lin, Lingjun Zhang, Michael Kong, Maojing Yang, Yinghua Chen, Earl Poptic, Melanie Hoffner, Jijun Xu, Connie Tam, Feng Lin

Blood Adv (2020) 4 (9): 2049–2057.

https://doi.org/10.1182/bloodadvances.2020001690

Published: 2020

Includes: Supplemental data

Journal Articles

Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program

Georg Gelbenegger, Christian Schoergenhofer, Ulla Derhaschnig, Nina Buchtele, Christian Sillaber, Michael Fillitz, Thomas M. Schenk, Shirley D’Sa, Ronwyn Cartwright, James C. Gilbert, Bernd Jilma, Ulrich Jaeger

Blood Adv (2020) 4 (6): 997–1005.

https://doi.org/10.1182/bloodadvances.2019001321

Published: 2020

Includes: Supplemental data

Journal Articles

Decoding the role of SOD2 in sickle cell disease

Atinuke M. Dosunmu-Ogunbi, Katherine C. Wood, Enrico M. Novelli, Adam C. Straub

Blood Adv (2019) 3 (17): 2679–2687.

https://doi.org/10.1182/bloodadvances.2019000527

Published: 2019

Journal Articles

Differences in Steap3 expression are a mechanism of genetic variation of RBC storage and oxidative damage in mice

Heather L. Howie, Ariel M. Hay, Karen de Wolski, Hayley Waterman, Jenna Lebedev, Xiaoyun Fu, Rachel Culp-Hill, Angelo D’Alessandro, James D. Gorham, Matthew S. Ranson, John D. Roback, Peter C. Thomson, James C. Zimring

Blood Adv (2019) 3 (15): 2272–2285.

https://doi.org/10.1182/bloodadvances.2019000605

Published: 2019

Includes: Supplemental data

Journal Articles

Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment

Quentin A. Hill, Anita Hill, Sigbjørn Berentsen

Blood Adv (2019) 3 (12): 1897–1906.

https://doi.org/10.1182/bloodadvances.2019000036

Published: 2019

Includes: Supplemental data

Journal Articles

Absence of complement component 3 does not prevent classical pathway–mediated hemolysis

Lingjun Zhang, Yang Dai, Ping Huang, Thomas L. Saunders, David A. Fox, Jijun Xu, Feng Lin

Blood Adv (2019) 3 (12): 1808–1814.

https://doi.org/10.1182/bloodadvances.2019031591

Published: 2019

Journal Articles

Effects of aged stored autologous red blood cells on human plasma metabolome

Angelo D’Alessandro, Julie A. Reisz, Yingze Zhang, Sarah Gehrke, Keisha Alexander, Tamir Kanias, Darrell J. Triulzi, Chenell Donadee, Suchitra Barge, Jessica Badlam, Shilpa Jain, Michael G. Risbano, Mark T. Gladwin

Blood Adv (2019) 3 (6): 884–896.

https://doi.org/10.1182/bloodadvances.2018029629

Published: 2019

Includes: Supplemental data

Journal Articles

Infused wild-type macrophages reside and self-renew in the liver to rescue the hemolysis and anemia of Hmox1 -deficient mice

Ki Soon Kim, De-Liang Zhang, Gennadiy Kovtunovych, Manik C. Ghosh, Hayden Ollivierre, Michael A. Eckhaus, Tracey A. Rouault

Blood Adv (2018) 2 (20): 2732–2743.

https://doi.org/10.1182/bloodadvances.2018019737

Published: 2018

Includes: Supplemental data

Journal Articles

Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial

Alexander Röth, Martin Bommer, Andreas Hüttmann, Dörte Herich-Terhürne, Nils Kuklik, Jan Rekowski, Veronika Lenz, Hubert Schrezenmeier, Ulrich Dührsen

Blood Adv (2018) 2 (19): 2543–2549.

https://doi.org/10.1182/bloodadvances.2018024190

Published: 2018

Journal Articles

Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity

Ruqayyah J. Almizraq, Philip J. Norris, Heather Inglis, Somaang Menocha, Mathijs R. Wirtz, Nicole Juffermans, Suchitra Pandey, Philip C. Spinella, Jason P. Acker, Jennifer A. Muszynski

Blood Adv (2018) 2 (18): 2296–2306.

https://doi.org/10.1182/bloodadvances.2018021931

Published: 2018

Includes: Supplemental data

Journal Articles

Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies

Alexander Röth, Scott T. Rottinghaus, Anita Hill, Eric S. Bachman, Jin Seok Kim, Hubert Schrezenmeier, Louis Terriou, Álvaro Urbano-Ispizua, Richard A. Wells, Jun Ho Jang, Austin G. Kulasekararaj, Jeff Szer, Rasha Aguzzi, Andrew I. Damokosh, Lori Shafner, Jong Wook Lee

Blood Adv (2018) 2 (17): 2176–2185.

https://doi.org/10.1182/bloodadvances.2018020644

Published: 2018

Includes: Supplemental data

Journal Articles

Elevated ecto-5′-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease

Hong Liu, Morayo Adebiyi, Rong Rong Liu, Anren Song, Jeanne Manalo, Yuan Edward Wen, Alexander Q. Wen, Tingting Weng, Junsuk Ko, Modupe Idowu, Rodney E. Kellems, Holger K. Eltzschig, Michael R. Blackburn, Harinder S. Juneja, Yang Xia

Blood Adv (2018) 2 (15): 1957–1968.

https://doi.org/10.1182/bloodadvances.2018015784

Published: 2018

Includes: Supplemental data

Journal Articles

Biocompatible coupling of therapeutic fusion proteins to human erythrocytes

Carlos H. Villa, Daniel C. Pan, Ian H. Johnston, Colin F. Greineder, Landis R. Walsh, Elizabeth D. Hood, Douglas B. Cines, Mortimer Poncz, Don L. Siegel, Vladimir R. Muzykantov

Blood Adv (2018) 2 (3): 165–176.

https://doi.org/10.1182/bloodadvances.2017011734

Published: 2018

Includes: Multimedia, Supplemental data

Journal Articles

Quantitative proteomics of plasma vesicles identify novel biomarkers for hemoglobin E/β-thalassemic patients

Janejira Kittivorapart, Vanja Karamatic Crew, Marieangela C. Wilson, Kate J. Heesom, Noppadol Siritanaratkul, Ashley M. Toye

Blood Adv (2018) 2 (2): 95–104.

https://doi.org/10.1182/bloodadvances.2017011726

Published: 2018

Includes: Supplemental data

Journal Articles

Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions

Priyanka Pandey, Waseem Q. Anani, Jerome L. Gottschall, Gregory A. Denomme

Blood Adv (2017) 1 (23): 1977–1982.

https://doi.org/10.1182/bloodadvances.2017008805

Published: 2017

Journal Articles

Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study

Tamir Kanias, Marion C. Lanteri, Grier P. Page, Yuelong Guo, Stacy M. Endres, Mars Stone, Sheila Keating, Alan E. Mast, Ritchard G. Cable, Darrell J. Triulzi, Joseph E. Kiss, Edward L. Murphy, Steve Kleinman, Michael P. Busch, Mark T. Gladwin

Blood Adv (2017) 1 (15): 1132–1141.

https://doi.org/10.1182/bloodadvances.2017004820

Published: 2017

Journal Articles

Associations of α-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohorts

Santosh L. Saraf, Titilola S. Akingbola, Binal N. Shah, Chinedu A. Ezekekwu, Omowunmi Sonubi, Xu Zhang, Lewis L. Hsu, Mark T. Gladwin, Roberto F. Machado, Richard S. Cooper, Victor R. Gordeuk, Bamidele O. Tayo

Blood Adv (2017) 1 (11): 693–698.

https://doi.org/10.1182/bloodadvances.2017005231

Published: 2017

NARROW

FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice

Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products

Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes

Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program

Decoding the role of SOD2 in sickle cell disease

Differences in Steap3 expression are a mechanism of genetic variation of RBC storage and oxidative damage in mice

Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment

Absence of complement component 3 does not prevent classical pathway–mediated hemolysis

Effects of aged stored autologous red blood cells on human plasma metabolome

Infused wild-type macrophages reside and self-renew in the liver to rescue the hemolysis and anemia of Hmox1 -deficient mice

Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial

Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity

Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies

Elevated ecto-5′-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease

Biocompatible coupling of therapeutic fusion proteins to human erythrocytes

Quantitative proteomics of plasma vesicles identify novel biomarkers for hemoglobin E/β-thalassemic patients

Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions

Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study

Associations of α-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohorts

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only